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Abstract
Klebsiella oxytoca (K. oxytoca) is a Gram-negative microbe generally associated with community and hospital-
acquired infections. Due to its clinical significance, we evaluated the effect of biofield treatment on phenotype and 
biotype characteristics of K. oxytoca (ATCC 43165). The study was performed into three groups i.e. C (control), 
T1 (treatment, revived); and T2 (treatment, lyophilized). Subsequently, groups T1 and T2 were received biofield 
treatment and control group was remained as untreated. The antimicrobial sensitivity results showed 3.33% and 
6.67% alteration in antimicrobials susceptibility in group T1 cells on day 5 and 10, respectively, and 3.33% alteration 
in antimicrobials susceptibility was observed in group T2 cells on day 10 as compared to control. The sensitivity 
patterns of cefazolin were changed from resistant (R) to intermediate (I) on day 5, and resistance (R) to susceptible 
(S) on day 10, in T1 cells of K. oxytoca. The MIC value of cefazolin was decreased by 2-fold in group T1 on day 
10 as compared to control. The biofield treated K. oxytoca exhibited the changes in biochemical reactions about 
3.03% and 15.15% of total tested biochemicals in group T1 cells on day 5 and 10, respectively as compared to 
control. The biotype number of K. oxytoca was altered in biofield treated group and organism identified as Raoultella 
ornithinolytica in T1 on day 10 as compared to control, which is the prominent finding of this study. These changes 
were found in treated bacteria that might be due to some alteration happened in metabolic/enzymatic pathway and/
or at genetic level of K. oxytoca. Based on these data, it is speculated that biofiled treatment could be an alternative 
approach that can improve the effectiveness of the existing antimicrobials against the resistant pathogens.
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Introduction
Microorganisms like bacteria, viruses, fungi, and parasites are 
continuously acquiring the resistance against existing antimicrobials 
that possess a major global threat to public health. In the latest report 
of World Health Organization (WHO) warned to the occurrence 
of post-antibiotic era, where people will die from simple microbial 
infections due to ineffectiveness of current antimicrobials. Frequent 
and improper use of antimicrobial further accelerated the incidence of 
microbial resistance [1,2].
Klebsiella oxytoca (K. oxytoca) is a rod-shaped, nonmotile, Gram-
negative bacterium with a prominent polysaccharide capsule, which 
provides a resistance against host defense mechanisms. Klebsiella 
species are normally associated with the community and hospital-
acquired infections particularly in immunocompromised patients. 
The patients having prostatectomies, neurosurgical procedures, 
intravascular catheters, colonoscopies, platelet transfusions, urinary 
tract infections (UTI), and pre-existing viral or antibiotic induced 
colitis are more prone to K. oxytoca infection [3].  K. oxytoca has 
developing the enzymes extended spectrum β-lactamases (ESBL) 
and carbapenemases that lead to bacterial resistance to β-lactam 
antibiotics. Therefore, K. oxytoca is usually resistant to some antibiotics 
like cefotaxime, ceftazidime and aztreonam [4,5]. Recently, biofield 
treatment is reported for the alteration in sensitivity of antimicrobials 
against the tested microorganism [6]. 
The conversion of mass into energy is well known in literature for 
hundreds of years that was further explained by Fritz [7] and Einstein 
[8]. The energy can exist in various forms like kinetic, potential, 
electrical, magnetic, and nuclear; and can be produced from different 
sources. Correspondingly, the nervous system of human also consists 
of neurons that have the ability to transmit information in the form 
of electrical signals [9-11]. Thus, human has the ability to harness the 
energy from environment or universe and can transmit into any living 
or nonliving object(s) around the globe. The objects always receive the 
energy and responding into useful way that is called biofield energy and 
the process is known as biofield treatment. 
Mr. Trivedi’s biofield treatment is well-known to change the 
various physicochemical characteristics of metals and ceramics 
[12-14]. The quality and yield of several agriculture products have 
also been improved with several folds in the biofield treated plants 
[15]. Exposure to biofield energy caused an increase in growth and 
anatomical characteristics of plant [16]. Further, the biofield treatment 
has considerably altered susceptibility of antimicrobials and biotype 
number of microbe [6,17,18]. 
By conceiving the above mentioned facts and literature reports 
on biofield, the present work was undertaken to evaluate the impact 
of biofield treatment on antimicrobials susceptibility, biochemical 
reactions pattern, and biotype of K. oxytoca. 
Materials and Methods
Two lyophilized vials of K. oxytoca [American Type Culture 
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Collection (ATCC) 43165] were procured from MicroBioLogics, Inc., 
USA. These vials were stored as per the suggested storage conditions 
till the further use. The antimicrobials susceptibility study, biochemical 
reactions patterns, and biotype number were evaluated on MicroScan 
Walk-Away® (Dade Behring Inc., West Sacramento, CA) using Negative 
Breakpoint Combo 30 (NBPC30) panel [19]. The antimicrobials and 
biochemicals used in the study were procured from Sigma-Aldrich. 
Study design 
The lyophilized cells of K. oxytoca were divided into three groups: 
C (control), T1 (treatment, revived) and T2 (treatment, lyophilized). 
The treatment groups (T1 and T2) were in sealed pack and handed over 
to Mr. Trivedi for biofield treatment under laboratory condition. Mr. 
Trivedi provided the treatment through his energy transmission process 
to the treated groups without touching the samples. Subsequently, 
groups C and T1 were assessed on day 5 and 10, and group T2 was 
assessed on day 10, for the antimicrobial sensitivity, biochemical 
reactions, and biotype number. 
Investigation of antimicrobial susceptibility of microorganism
The antimicrobial susceptibility study was carried out on MicroScan 
Walk-Away® using negative breakpoint combo 30 (NBPC30) panel, as 
per manufacturer's instructions. Briefly, the standardized suspension 
of K. oxytoca were inoculated, rehydrated, and then subjected to 
incubation for 16 h at 35°C. After that, the susceptibility pattern like 
susceptible (S), intermediate (I) or resistant (R); and quantitative 
susceptibility in terms of minimum inhibitory concentration (MIC) 
were determined by observing the lowest antimicrobial concentration 
showing growth inhibition [20-22]. The antimicrobials used for the 
sensitivity study were  amikacin, amoxicillin/K-clavulanate, ampicillin/
sulbactam, ampicillin, aztreonam, cefazolin, cefepime, cefotaxime, 
cefotetan, cefoxitin, ceftazidime, ceftriaxone, cefuroxime, cephalothin, 
chloramphenicol, ciprofloxacin, gatifloxacin, gentamicin, imipenem, 
levofloxacin, meropenem, moxifloxacin, nitrofurantoin, norfloxacin, 
piperacillin, tazobactam, tetracycline, ticarcillin/K- clavulanate, 
tobramycin,  and trimethoprim/sulfamethoxazole. 
Study of biochemical reaction
The study of biochemical reactions was carried out on MicroScan 
Walk-Away® system [23]. The biochemicals used in present work 
were acetamide, adonitol, arabinose, arginine, cetrimide, cephalothin, 
citrate, colistin, esculin hydrolysis, nitrofurantoin, glucose, hydrogen 
sulfide, indole, inositol, kanamycin, lysine, malonate, melibiose, 
nitrate, oxidation-fermentation, galactosidase, ornithine, oxidase, 
penicillin, raffinose, rhaminose, sorbitol, sucrose, tartarate, tryptophan 
deaminase, tobramycin, urea and Voges-Proskauer. 
Assessment of biotype number
Effect of biofield treatment on biotype number and organism 
identification were determined using MicroScan Walk-Away® 
processed panel data report [20]
Results
Antimicrobial susceptibility assay
The results of antimicrobial susceptibility study and MIC values 
are summarized in Table 1 and 2, respectively. The results showed 
about 3.33% and 6.67% alteration in antimicrobials susceptibility in 
group T1 cells on day 5 and 10, respectively, and 3.33% alteration in 
antimicrobials susceptibility was found in group T2 cells on day 10 as 
compared to control. Concisely, the K. oxytoca was converted from 
S → I against ampicillin/sulbactam in T2 cells on day 10; and R → I 
and S against cefazolin in T1 cells on day 5 and 10, respectively. The 
K. oxytoca showed an alteration from S → R against tetracycline in T1 
cells on day 10. The MIC data suggested about 2-folds decrease in MIC 
value of cefazolin, and more than 2-folds increase in MIC value of 
tetracycline in T1 cells of K. oxytoca on day 10, as compared to control. 
Furthermore, the susceptibility pattern of K. oxytoca to ampicillin/
sulbactam was also changed from S → I in T2 cell on day 10 with about 
2-folds increase in MIC value as compared to control (Table 2). 
Identification of K. oxytoca using biochemical reactions 
pattern
The biochemical reactions data are shown in Table 3. K. oxytoca 
exhibited an alteration in biochemical reactions about 3.03% and 
15.15% of total tested biochemicals on day 5 and 10, respectively. 
The colistin, nitrofurantoin, hydrogen sulfide, and ornithine were 
converted from negative (–) to positive (+) reaction in group T1 on 
day 10, and tartarate was converted from positive (+) to negative 
(–) reaction in group T1 on both day 5 and 10. The results showed 
no change in biochemical reactions patterns of group T2 cells, as 
compared to control (Table 3). 
Effect of biofield treatment on biotype number 
S. No. Antimicrobial C 
T1
T2 day 10
day 5 day 10
1 Amikacin S S S S
2 Amoxicillin/K-clavulanate S S S S
3 Ampicillin/Sulbactam S S S I
4 Ampicillin R R R R
5 Aztreonam S S S S
6 Cefazolin R I S R
7 Cefepime S S S S
8 Cefotaxime S S S S
9 Cefotetan S S S S
10 Cefoxitin S S S S
11 Ceftazidime S S S S
12 Ceftriaxone S S S S
13 Cefuroxime S S S S
14 Cephalothin S S S S
15 Chloramphenicol S S S S
16 Ciprofloxacin S S S S
17 Gatifloxacin S S S S
18 Gentamicin S S S S
19 Imipenem S S S S
20 Levofloxacin S S S S
21 Meropenem S S S S
22 Moxifloxacin S S S S
23 Nitrofurantoin R R R R
24 Norfloxacin S S S S
25 Piperacillin S S S S
26 Tazobactam S S S S
27 Tetracycline S S R S
28 Ticarcillin/K clavulanate S S S S
29 Tobramycin S S S S
30 Trimethoprim/sulfamethoxazole S S S S
C: Control group; T: Treatment group; I: Intermediate; S: Susceptible; R: Resistant
Table 1: Effect of biofield treatment on K. oxytoca to antimicrobial susceptibility.
Citation: Trivedi MK, Patil S, Shettigar H, Bairwa K, Jana S (2015) Phenotypic and Biotypic Characterization of Klebsiella oxytoca: An Impact of 
Biofield Treatment. J Microb Biochem Technol 7:4 202-205. doi:10.4172/1948-5948.1000204
Volume 7(4): 202-205 (2015) - 204J Microb Biochem Technol ISSN: 1948-5948 JMBT, an open access journal
S. No. Antimicrobial C 
T1 T2 day 
10day 5 day 10
1 Amikacin ≤16 ≤16 ≤16 ≤16
2 Amoxicillin/K-clavulanate ≤8/4 ≤8/4 ≤8/4 ≤8/4
3 Ampicillin/Sulbactam ≤8/4 ≤8/4 ≤8/4 16/8
4 Ampicillin >16 >16 >16 >16
5 Aztreonam ≤8 ≤8 ≤8 ≤8
6 Cefazolin >16 16 ≤8 >16
7 Cefepime ≤8 ≤8 ≤8 ≤8
8 Cefotaxime ≤8 ≤8 ≤8 ≤8
9 Cefotetan ≤16 ≤16 ≤16 ≤16
10 Cefoxitin ≤8 ≤8 ≤8 ≤8
11 Ceftazidime ≤8 ≤8 ≤8 ≤8
12 Ceftriaxone ≤8 ≤8 ≤8 ≤8
13 Cefuroxime ≤4 ≤4 ≤4 ≤4
14 Cephalothin ≤8 ≤8 ≤8 ≤8
15 Chloramphenicol ≤8 ≤8 ≤8 ≤8
16 Ciprofloxacin ≤1 ≤1 ≤1 ≤1
17 Gatifloxacin ≤2 ≤2 ≤2 ≤2
18 Gentamicin ≤4 ≤4 ≤4 ≤4
19 Imipenem ≤4 ≤4 ≤4 ≤4
20 Levofloxacin ≤2 ≤2 ≤2 ≤2
21 Meropenem ≤4 ≤4 ≤4 ≤4
22 Moxifloxacin ≤2 ≤2 ≤2 ≤2
23 Nitrofurantoin ≤32 ≤32 >64 ≤32
24 Norfloxacin ≤4 ≤4 ≤4 ≤4
25 Piperacillin ≤16 ≤16 ≤16 ≤16
26 Tazobactam ≤16 ≤16 ≤16 ≤16
27 Tetracycline ≤4 ≤4 >8 ≤4
28 Ticarcillin/K clavulanate ≤16 ≤16 ≤16 ≤16
29 Tobramycin ≤4 ≤4 ≤4 ≤4
30 Trimethoprim/sulfamethoxazole ≤2/38 ≤2/38 ≤2/38 ≤2/38
C: Control group; T: Treatment group; MIC data is presented in µg/mL
Table 2: Effect of biofield treatment on K. oxytoca to minimum inhibitory 
concentration (MIC) of tested antimicrobial.
Biotype number of K. oxytoca was determined on MicroScan 
Walk-Away® processed panel, using biochemical reactions data. The 
result demonstrated an alteration in biotype number of K. oxytoca in 
group T1 on day 10, as compared to control. The change in the species 
from K. oxytoca to Raoultella ornithinolytica (formerly  known as 
Klebsiella ornithinolytica) was also found in group T1 on day 10 (Table 
4), which describes the most significant impact of biofield treatment 
in this study. 
Discussion 
Antimicrobial resistance in several microbes has been increased 
vigorously in recent time. Generally, microorganisms mutate and 
finally become resistant to antibiotics. Unfortunately, due to improper 
or misuse of antimicrobials the incidences of antimicrobial resistance 
in microbes are observing in faster rate than expected [24]. As a result, 
discovery of antimicrobial drug therapy is a slow and time-consuming 
process. Recently, there are reports wherein, the susceptibility of 
microbe was altered from resistance to susceptible or inversely using 
the biofield treatment [17,18]. Therefore, present work investigates 
the effect of biofield treatment on K. oxytoca, and evaluated its impact 
on susceptibility and biochemical reactions pattern to the selected 
antimicrobials and biochemicals. 
Recently, K. oxytoca is acquiring resistant to some cephalosporins 
and fluoroquinolones antifungal drugs. K. oxytoca have an inherent 
enzyme β-lactamase that confers a low-level resistance to penicillins. 
It also carries the efflux pump on the cell wall that causes reduced 
intracellular concentrations of antimicrobials and induces phenotypic 
resistance [4,5,25-27]. The sensitivity of K. oxytoca before and 
after treatment was determined by comparing the MIC value of 
antimicrobial to the attainable blood or urine level as per the Clinical 
and Laboratory Standards Institute (CLSI) guideline. The results of 
antifungal sensitivity study revealed the changes in antimicrobial 
sensitivity and MIC values of few tested antimicrobials like ampicillin/
sulbactam, cefazolin, and tetracycline against K. oxytoca. Cefazolin is a 
first-generation cephalosporin that was initially used for wide range of 
microbial infections. In the present study, K. oxytoca showed resistance 
to cefazolin in control sample; however, after biofield treatment, the 
sensitivity was changed from resistant to intermediate and susceptible 
on 5 and 10 day, respectively. It revealed that using biofield treatment K. 
oxytoca infection can be effectively overcome by cefazolin. Contrarily, 
the results also showed the alteration in the sensitivity of K. oxytoca 
S. No. Code Biochemical C 
T1 T2 day 
10day 5 day 10
1 ACE Acetamide - - - -
2 ADO Adonitol + + + +
3 ARA Arabinose + + + +
4 ARG Arginine - - - -
5 CET Cetrimide - - - -
6 CF8 Cephalothin - - - -
7 CIT Citrate + + + +
8 CL4 Colistin - - + -
9 ESC Esculin hydrolysis + + + +
10 FD64 Nitrofurantoin - - + -
11 GLU Glucose + + + +
12 H2S Hydrogen sulfide - - + -
13 IND Indole + + + +
14 INO Inositol + + + +
15 K4 Kanamycin - - - -
16 LYS Lysine + + + +
17 MAL Malonate + + + +
18 MEL Melibiose + + + +
19 NIT Nitrate + + + +
20 OF/G Oxidation-Fermentation + + + +
21 ONPG Galactosidase + + + +
22 ORN Ornithine - - + -
23 OXI Oxidase - - - -
24 P4 Penicillin + + + +
25 RAF Raffinose + + + +
26 RHA Rhaminose + + + +
27 SOR Sorbitol + + + +
28 SUC Sucrose + + + +
29 TAR Tartarate + - - +
30 TDA Tryptophan Deaminase - - - -
31 TO4 Tobramycin - - - -
32 URE Urea + + + +
33 VP Voges-Proskauer + + + +
C: Control group; T: Treatment group; - : (negative); + : (positive)
Table 3: Effect of biofield treatment on K. oxytoca to biochemical reactions.
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from susceptible to intermediate or resistant to a few antimicrobials. 
The MIC values of some antimicrobials were also altered accordingly 
to changes in sensitivity patterns of K. oxytoca. Overall, the result of 
present study indicated that biofield treatment has the ability to alter 
the susceptibility of microbes in both direction either susceptible to 
resistant or resistant to susceptible. 
Biochemical methods employed to identify or classify the bacterial 
species based on their biochemical reactions. Several biochemical 
tests like indole production, ornithine decarboxylation, and carbon 
substrate assimilation tests have been reported in literature for the 
identification of K. oxytoca. It usually exhibited the positive reactions 
to indole, malonate, urease, Voges-Proskauer; and negative reactions to 
arginine, colistin, hydrogen sulfide, and ornithin [28]. Similar reactions 
patterns were also observed in this study for control sample of K. 
oxytoca. However, after biofield treatment some biochemical reactions 
pattern were altered like ornithine, hydrogen sulfide, colistin etc. These 
biochemical were changed from negative to positive reactions in group 
T1 on day 10. As well, tartarate was converted from positive to negative 
reaction in group T1 on both day 5 and 10. These data suggested the 
impact of biofield treatment on metabolic pathway of K. oxytoca. 
Alterations in biochemical reactions were attributed to changes in 
biotype number of K. oxytoca that was found in group T1 on day 10. 
Wherein the biotype number and species were altogether changed and 
the new species was identified as R. ornithinolytica. 
Conclusions 
Overall data conclude that there was an alteration in antimicrobial 
sensitivity, biochemical reactions patterns, and biotype number 
of biofield treated K. oxytoca. These results depicted that biofield 
treatment has the ability to make some alteration at the enzymatic or 
metabolic pathway and/or at genetic level of K. oxytoca. Therefore, in 
future the biofield treatment could be useful as an alternative method 
to prevent the infections of pathogenic microbes.
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